Figure 1.

Association between cytoplasmic CAV1 expression and clinical outcome in all patients (Kaplan-Meier; n = 169): The overall survival of patients with a higher-than-average CAV1 expression in the tumor cell cytoplasm was significantly shorter compared with that of patients lower CAV1 levels. 5-year survival rates were calculated at 51.4% and 75.2% (p = 0.001, Mantel-Cox).

Steffens et al. BMC Urology 2011 11:25   doi:10.1186/1471-2490-11-25
Download authors' original image